These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6946351)

  • 41. [Organization and management of Czechoslovak pharmacy].
    Salava M; Vokrouhlíková J
    Cesk Zdrav; 1980 May; 28(5):213-5. PubMed ID: 7379199
    [No Abstract]   [Full Text] [Related]  

  • 42. [The EEC creates a European Medical Product Agency].
    Johnson K
    Lakartidningen; 1993 Oct; 90(40):3395. PubMed ID: 8231477
    [No Abstract]   [Full Text] [Related]  

  • 43. R&D technology investments: misguided and expensive or a better way to discover medicines?
    Schmid EF; Smith DA
    Drug Discov Today; 2006 Sep; 11(17-18):775-84. PubMed ID: 16935744
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Optimizing the impact of genomics on drug discovery and development.
    Crooke ST
    Nat Biotechnol; 1998 May; 16 Suppl():29-30. PubMed ID: 9591260
    [No Abstract]   [Full Text] [Related]  

  • 45. [Drug targets: identification and evaluation].
    Mikkelsen JD
    Ugeskr Laeger; 2005 May; 167(20):2156-60. PubMed ID: 15987072
    [No Abstract]   [Full Text] [Related]  

  • 46. [Programming of production in relation to that of sales and supplies. I].
    Bellentani L
    Boll Chim Farm; 1970 Mar; 109(3):180-96. PubMed ID: 5488953
    [No Abstract]   [Full Text] [Related]  

  • 47. More on the Swedish "experiment".
    Eriksson LV; Schwartz FE
    J Am Pharm Assoc; 1973 Apr; 13(4):172 passim. PubMed ID: 4696157
    [No Abstract]   [Full Text] [Related]  

  • 48. Disbursement of indemnity for injuries related to reproductive drugs and devices: a Swedish perspective.
    Westerhall L
    Rev Law Soc Change; 1997; 23(3):443-56. PubMed ID: 10725055
    [No Abstract]   [Full Text] [Related]  

  • 49. [Pharmaceutical specialties registered in Sweden in 1966: important information could still be improved].
    Rosén A
    Lakartidningen; 1966 Mar; 63(12):1126-8. PubMed ID: 5919973
    [No Abstract]   [Full Text] [Related]  

  • 50. [Machinery and production lines for drugs].
    Colosi E; Giannini M; Giusti E; Lattanzi F; Lencioni E; Reghini A; Zannotti A
    Boll Chim Farm; 1980 May; 119(5):253-60. PubMed ID: 7459047
    [No Abstract]   [Full Text] [Related]  

  • 51. Boston means business for drug companies.
    Mervis J
    Science; 2005 Jul; 309(5735):723. PubMed ID: 16051782
    [No Abstract]   [Full Text] [Related]  

  • 52. Where is the optimism? Warrior teachings to regain the drug discovery spirit.
    Uitdehaag JC
    Drug Discov Today; 2007 Feb; 12(3-4):105-7. PubMed ID: 17275729
    [No Abstract]   [Full Text] [Related]  

  • 53. Pharmaceuticals in the year 2000.
    Crozier D
    Health Aff (Millwood); 1982; 1(2):115-7. PubMed ID: 10256510
    [No Abstract]   [Full Text] [Related]  

  • 54. Advances in knowledge management for pharmaceutical research and development.
    Torr-Brown S
    Curr Opin Drug Discov Devel; 2005 May; 8(3):316-22. PubMed ID: 15892246
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Surviving the blockbuster syndrome.
    Service RF
    Science; 2004 Mar; 303(5665):1796-9. PubMed ID: 15031490
    [No Abstract]   [Full Text] [Related]  

  • 56. Hospital cost controls will stifle new drug technology.
    Hoffmann RP
    Hosp Pharm; 1983 Aug; 18(8):397. PubMed ID: 10261789
    [No Abstract]   [Full Text] [Related]  

  • 57. [Final reply: drug companies must be allowed to make profit].
    Lafolie P
    Lakartidningen; 2006 Jun 14-27; 103(24-25):1979. PubMed ID: 16838588
    [No Abstract]   [Full Text] [Related]  

  • 58. [Quality control changes in release controller system].
    Smewing J
    Boll Chim Farm; 2001; 140(3):192-4. PubMed ID: 11486613
    [No Abstract]   [Full Text] [Related]  

  • 59. Quality: an old solution to new discovery dilemmas?
    Volsen SG; Kent JM; Masson M
    Drug Discov Today; 2004 Nov; 9(21):903-5. PubMed ID: 15501718
    [No Abstract]   [Full Text] [Related]  

  • 60. Danish merger.
    Newmark P
    Nature; 1989 May; 339(6219):5. PubMed ID: 2716829
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.